BOSTON — Invitrogen last week said that researchers at the Burnham Institute are using its NCode miRNA arrays to study embryonic stem cells.
The company also said that it has abandoned a similar deal with Johns Hopkins University because of restrictions placed on the kinds of embryonic stem cell lines that can be used outside of California.
Invitrogen also has embryonic stem cell collaborations with Rutgers University and American Type Culture Collection.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.